Overview

Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100)

Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety of administering repeated doses of CTX-100 (formerly ETX-100) to subjects with smoking-related chronic obstructive pulmonary disease.
Phase:
Phase 2
Details
Lead Sponsor:
Turino, Gerard, M.D.
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Hyaluronic Acid
Pharmaceutical Solutions